{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:47:09Z","timestamp":1762145229501},"reference-count":21,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b16-00590","type":"journal-article","created":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T22:12:17Z","timestamp":1483222337000},"page":"56-60","source":"Crossref","is-referenced-by-count":4,"title":["Differential Contribution of Nerve-Derived Noradrenaline to High K&lt;sup&gt;+&lt;\/sup&gt;-Induced Contraction Depending on Type of Artery"],"prefix":"10.1248","volume":"40","author":[{"given":"Hirotake","family":"Ishida","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ya","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eita","family":"Hishinuma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Jackson WF. Ion channels and vascular tone. <i>Hypertension<\/i>, <b>35<\/b>, 173\u2013178 (2000).","DOI":"10.1161\/01.HYP.35.1.173"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Marriott JF. A comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein. <i>Br. J. Pharmacol.<\/i>, <b>95<\/b>, 145\u2013154 (1988).","DOI":"10.1111\/j.1476-5381.1988.tb16558.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Vanhoutee PM, Verbeuren TJ. Inhibition by acetylcholine of the norepinephrine release evoked by potassium in canine saphenous veins. <i>Circ. Res.<\/i>, <b>39<\/b>, 263\u2013269 (1976).","DOI":"10.1161\/01.RES.39.2.263"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Takata Y, Kato H. Effects of Ca antagonists on the norepinephrine release and contractile responses of isolated canine saphenous veins to high KCl. <i>Jpn. J. Pharmacol.<\/i>, <b>37<\/b>, 381\u2013394 (1985).","DOI":"10.1254\/jjp.37.381"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kobayashi Y, Freas W, Muldoon SM. Effects of enflurane on adrenergic function in canine mesenteric artery and vein. <i>Anesth. Analg.<\/i>, <b>81<\/b>, 265\u2013271 (1995).","DOI":"10.1097\/00000539-199508000-00010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zelis R, Wichmann T, Starke T. Inhibition by diltiazem of norepinephrine release from sympathetic nerves in the rabbit pulmonary artery. <i>Pharmacology<\/i>, <b>31<\/b>, 268\u2013277 (1985).","DOI":"10.1159\/000138131"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nilsson H, Goldstein M, Nilsson O. Adrenergic innervation and neurogenic response in large and small arteries and veins from the rat. <i>Acta Physiol. Scand.<\/i>, <b>126<\/b>, 121\u2013133 (1986).","DOI":"10.1111\/j.1748-1716.1986.tb07795.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Reho JJ, Zheng X, Fisher SA. Smooth muscle contractile diversity in the control of regional circulations. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>306<\/b>, H163\u2013H172 (2014).","DOI":"10.1152\/ajpheart.00493.2013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Goto K, Saito S, Ishikawa T. Enhanced vasoconstriction to \u03b1<sub>1<\/sub>-adrenoceptor stimulation during cooling in mouse cutaneous plantar arteries. <i>Eur. J. Pharmacol.<\/i>, <b>742<\/b>, 1\u20137 (2014).","DOI":"10.1016\/j.ejphar.2014.08.014"},{"key":"10","unstructured":"10) Iwasaki H, Mori Y, Hara Y, Uchida K, Zhou H, Mikoshiba K. 2-Aminoethoxydiphenyl borate (2-APB) inhibits capacitative calcium entry independently of the function of inositol 1,4,5-triphosphate rceptors. <i>Receptors Channels<\/i>, <b>7<\/b>, 429\u2013439 (2001)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lee CH, Rahimian R, Szado T, Sandhu J, Poburko D, Behra T, Chan L, van Breemen C. Sequential opening of IP<sub>3<\/sub>-sensitive Ca<sup>2+<\/sup> channels and SOC during \u03b1-adrenergic activation of rabbit vena cava. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>282<\/b>, H1768\u2013H1777 (2002).","DOI":"10.1152\/ajpheart.00637.2001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kennedy C. ATP as a cotransmitter in the autonomic nervous system. <i>Auton. Neurosci.<\/i>, <b>191<\/b>, 2\u201315 (2015).","DOI":"10.1016\/j.autneu.2015.04.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Poburko D, Liao CH, Lemos VS, Lin E, Maruyama Y, Cole WC, van Breemen C. Transient receptor potential channel 6-mediated, localized cytosolic [Na<sup>+<\/sup>] transients drive Na<sup>+<\/sup>\/Ca<sup>2+<\/sup> exchanger-mediated Ca<sup>2+<\/sup> entry in purinergically stimulated aorta smooth muscle cells. <i>Circ. Res.<\/i>, <b>101<\/b>, 1030\u20131038 (2007).","DOI":"10.1161\/CIRCRESAHA.107.155531"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Weirich J, Seiler L, Hug MJ, Fleckenstein-Gr\u00fcn G. Ca<sup>2+<\/sup> entry into primary cultured pig coronary smooth muscle cells after previous store depletion by repetitive P2Y purinoceptor stimulation. <i>Cell Calcium<\/i>, <b>29<\/b>, 359\u2013367 (2001).","DOI":"10.1054\/ceca.2001.0198"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Matsuura M, Saino T, Satoh Y. Response to ATP is accompanied by a Ca<sup>2+<\/sup> influx <i>via<\/i> P2X purinoceptors in the coronary arterioles of golden hamsters. <i>Arch. Histol. Cytol.<\/i>, <b>67<\/b>, 95\u2013105 (2004).","DOI":"10.1679\/aohc.67.95"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ralevic V, Burnstock G. Roles of P2-purinoceptors in the cardiovascular system. <i>Circulation<\/i>, <b>84<\/b>, 1\u201314 (1991).","DOI":"10.1161\/01.CIR.84.1.1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Dalziel HH, Machaly M, Sneddon P. Comparison of the purinergic contribution to sympathetic vascular responses in SHR and WKY rats <i>in vitro<\/i> and <i>in vivo<\/i>. <i>Eur. J. Pharmacol.<\/i>, <b>173<\/b>, 19\u201326 (1989).","DOI":"10.1016\/0014-2999(89)90004-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Speirs L, Donnelly A, Lynch J, Scholfield CN, Johnson C. ATP and norepinephrine contributions to sympathetic vasoconstriction of tail artery are altered in streptozotocin-diabetic rats. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>291<\/b>, H2327\u2013H2333 (2006).","DOI":"10.1152\/ajpheart.01298.2005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Steinsland OS, Furchgott RF, Kirpekar SM. Biphasic vasoconstriction of the rabbit ear artery. <i>Circ. Res.<\/i>, <b>32<\/b>, 49\u201358 (1973).","DOI":"10.1161\/01.RES.32.1.49"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Bevan JA, Waterson JG. Biphasic constrictor response of the rabbit ear artery. <i>Circ. Res.<\/i>, <b>28<\/b>, 655\u2013661 (1971).","DOI":"10.1161\/01.RES.28.6.655"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Khayyal M, Gross F, Kreye VA. Differential effects of hydralazine on the biphasic responses of helical strips from rat tail arteries. <i>Gen. Pharmacol.<\/i>, <b>14<\/b>, 121\u2013123 (1983).","DOI":"10.1016\/0306-3623(83)90079-4"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/1\/40_b16-00590\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T03:03:11Z","timestamp":1568689391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/1\/40_b16-00590\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00590","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}